Molecular imaging for personalised treatment of cancer
2014-01-01 Oyen, W
Imaging of epidermal growth factor receptor expression in head and neck cancer xenografts with ultra high resolution single- photon emission computed tomography (USPECT) with 111In-labeled Cetuximab-F(ab ')2
2012-01-01 van Dijk, L; Franssen, G; Stegeman, H; Oyen, W; Kaanders, H; Boerman, O; Bussink, J
Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update
2012-01-01 Schoffelen, R; van der Graaf, W; Sharkey, R; Boerman, O; Visser, E; Mcbride, W; Rossi, E; Chang, Ch; Goldenberg, D; Oyen, W
Multi-modality imaging to predict response to systemic treatment in colorectal cancer: Preliminary results
2012-01-01 Heijmen, L; de Geus-Oei, Lf; ter Voert, E; Heerschap, A; van Spronsen, Dj; Oyen, W; Punt, C; van Laarhoven, H
Biodistribution of In-111-labeled D2B IgG, F(ab')(2) and Fab fragments in nude mice bearing human prostate cancer xenografts
2012-01-01 Lutje, S; Franssen, G; Helfrich, W; Fracasso, G; Colombatti, M; van Rij, C; Oyen, W; Boerman, O
The effect of bevacizumab on targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies.
2012-01-01 Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; Van der Graaf, Wta; Van Laarhoven, Hwm
The value of FDG-PET/CT in diagnosis and during follow-up of 273 patients with chronic Q fever
2016-01-01 Kouijzer, I; Aarntzen, E; Kampschreur, L; Wever, P; Hoekstra, C; van Kasteren, M; de Jager-Leclerque, M; Nabuurs-Franssen, M; Wegdam-Blans, M; de Geus-Oei, L; Oyen, W; Bleeker-Rovers, C
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis
2017-01-01 Lobeek, D; Terry, Sya; Franssen, Gm; Ma, Mt; Wester, H; Decristoforo, S; Oyen, W; Boerman, Oc; Rijpkema, M
Targeted dual-modality image-guided surgery using monoclonal antibodies in preclinical tumor models
2014-01-01 Hekman, M; Rijpkema, M; Lutje, S; Muselaers, S; Bos, D; Franssen, G; Oyen, W; Boerman, O
Immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in athymic mice with intraperitoneal human colon cancer lesions: Pretargeting theranostics
2012-01-01 Schoffelen, R; van der Graaf, Wta; Sharkey, Rm; Franssen, Gm; Mcbride, W; Chang, C; Bos, Dl; Goldenberg, Dm; Oyen, W; Boerman, Oc
FLT-PET during (chemo)radiotherapy in head and neck cancer patients: an early Predictor for the Long-term outcome
2012-01-01 Hoeben, Baw; Troost, Egc; van Herpen, Cm; Bussink, J; Oyen, W; Kaanders, Jham
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER
2012-01-01 Sonderen, Mj; Desar, Ime; De Geus-Oei, L; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml
Scintigraphic evaluation of experimental chronic osteomyelitis.
1998-01-01 Dams, Etm; Nijhof, Mw; Boerman, Oc; Laverman, P; Storm, G; Lemmens, Jam; van der Meer, Jwm; Corstens, Fhm; Oyen, W
Cost-effectiveness of FDG-PET for the detection of unknown primary tumours presenting as a lymph node metastasis in the neck
2007-01-01 Roodenburg, Jln; Pruim, J; Prost, Wj; de Bree, R; van den Hoogen, Fja; van der Werff-Regelink, G; Hoekstra, Os; Marres, Ham; van der Laan, Bfam; Oyen, W
Imaging expression of vascular endothelial growth factor (VEGF) in tumors with a radiolabeled anti-VEGF monoclonal antibody
2007-01-01 Boerman, Oc; Stollman, T; Scheer, M; Franssen, G; Corstens, Fhm; Ruers, Tjm; Oyen, W
BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors
2019-01-01 Clarke, J; Chu, S C; Siu, L L; Machiels, J P; Markman, B; Heinhuis, K; Millward, M; Lolkema, M; Patel, S P; de Souza, P; Curigliano, G; Santoro, A; Brown, M; Fleming, R; Veniza, H; He, C S; Rottey, S
FLT-PET-CT FOR EARLY TREATMENT RESPONSE MONITORING IN HEAD AND NECK TUMOURS
2010-01-01 Troost, E; Bussink, J; Hoffmann, A; Boerman, O; Oyen, W; Kaanders, J
Pretargeted radioimmunotherapy with Bi-213 in mice with CEA-expressing colon cancer xenografts
2015-01-01 Heskamp, S; Hernandez, R; Essler, M; Bruchertseifer, F; Morgenstern, A; Oyen, W; Seidl, C; Mcbride, B; Goldenberg, D; Boerman, O
Alpha- versus beta-emitting particles for pretargeted radioimmunotherapy of CEA-expressing human colon cancer xenografts
2015-01-01 Heskamp, S; Hernandez, R; Molkenboer-Kuenen, Jdm; Essler, M; Bruchertseifer, F; Morgenstern, A; Oyen, W; Seidl, C; Mcbride, W; Goldenberg, Dm; Boerman, Oc
Tumor segmentation and quantitative assessment of glucose metabolism for different histological types of NSCLC using dynamic F-18-FDG PET
2016-01-01 Meijer, T; De Geus-Oei, Lf; Visser, E; Oyen, W; Looijen-Salamon, M; Visvikis, D; Verhagen, A; Bussink, J; Vriens, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Molecular imaging for personalised treatment of cancer | 1-gen-2014 | Oyen, W | |
| Imaging of epidermal growth factor receptor expression in head and neck cancer xenografts with ultra high resolution single- photon emission computed tomography (USPECT) with 111In-labeled Cetuximab-F(ab ')2 | 1-gen-2012 | van Dijk, L; Franssen, G; Stegeman, H; Oyen, W; Kaanders, H; Boerman, O; Bussink, J | |
| Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update | 1-gen-2012 | Schoffelen, R; van der Graaf, W; Sharkey, R; Boerman, O; Visser, E; Mcbride, W; Rossi, E; Chang, Ch; Goldenberg, D; Oyen, W | |
| Multi-modality imaging to predict response to systemic treatment in colorectal cancer: Preliminary results | 1-gen-2012 | Heijmen, L; de Geus-Oei, Lf; ter Voert, E; Heerschap, A; van Spronsen, Dj; Oyen, W; Punt, C; van Laarhoven, H | |
| Biodistribution of In-111-labeled D2B IgG, F(ab')(2) and Fab fragments in nude mice bearing human prostate cancer xenografts | 1-gen-2012 | Lutje, S; Franssen, G; Helfrich, W; Fracasso, G; Colombatti, M; van Rij, C; Oyen, W; Boerman, O | |
| The effect of bevacizumab on targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies. | 1-gen-2012 | Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; Van der Graaf, Wta; Van Laarhoven, Hwm | |
| The value of FDG-PET/CT in diagnosis and during follow-up of 273 patients with chronic Q fever | 1-gen-2016 | Kouijzer, I; Aarntzen, E; Kampschreur, L; Wever, P; Hoekstra, C; van Kasteren, M; de Jager-Leclerque, M; Nabuurs-Franssen, M; Wegdam-Blans, M; de Geus-Oei, L; Oyen, W; Bleeker-Rovers, C | |
| A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis | 1-gen-2017 | Lobeek, D; Terry, Sya; Franssen, Gm; Ma, Mt; Wester, H; Decristoforo, S; Oyen, W; Boerman, Oc; Rijpkema, M | |
| Targeted dual-modality image-guided surgery using monoclonal antibodies in preclinical tumor models | 1-gen-2014 | Hekman, M; Rijpkema, M; Lutje, S; Muselaers, S; Bos, D; Franssen, G; Oyen, W; Boerman, O | |
| Immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in athymic mice with intraperitoneal human colon cancer lesions: Pretargeting theranostics | 1-gen-2012 | Schoffelen, R; van der Graaf, Wta; Sharkey, Rm; Franssen, Gm; Mcbride, W; Chang, C; Bos, Dl; Goldenberg, Dm; Oyen, W; Boerman, Oc | |
| FLT-PET during (chemo)radiotherapy in head and neck cancer patients: an early Predictor for the Long-term outcome | 1-gen-2012 | Hoeben, Baw; Troost, Egc; van Herpen, Cm; Bussink, J; Oyen, W; Kaanders, Jham | |
| A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER | 1-gen-2012 | Sonderen, Mj; Desar, Ime; De Geus-Oei, L; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml | |
| Scintigraphic evaluation of experimental chronic osteomyelitis. | 1-gen-1998 | Dams, Etm; Nijhof, Mw; Boerman, Oc; Laverman, P; Storm, G; Lemmens, Jam; van der Meer, Jwm; Corstens, Fhm; Oyen, W | |
| Cost-effectiveness of FDG-PET for the detection of unknown primary tumours presenting as a lymph node metastasis in the neck | 1-gen-2007 | Roodenburg, Jln; Pruim, J; Prost, Wj; de Bree, R; van den Hoogen, Fja; van der Werff-Regelink, G; Hoekstra, Os; Marres, Ham; van der Laan, Bfam; Oyen, W | |
| Imaging expression of vascular endothelial growth factor (VEGF) in tumors with a radiolabeled anti-VEGF monoclonal antibody | 1-gen-2007 | Boerman, Oc; Stollman, T; Scheer, M; Franssen, G; Corstens, Fhm; Ruers, Tjm; Oyen, W | |
| BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors | 1-gen-2019 | Clarke, J; Chu, S C; Siu, L L; Machiels, J P; Markman, B; Heinhuis, K; Millward, M; Lolkema, M; Patel, S P; de Souza, P; Curigliano, G; Santoro, A; Brown, M; Fleming, R; Veniza, H; He, C S; Rottey, S | |
| FLT-PET-CT FOR EARLY TREATMENT RESPONSE MONITORING IN HEAD AND NECK TUMOURS | 1-gen-2010 | Troost, E; Bussink, J; Hoffmann, A; Boerman, O; Oyen, W; Kaanders, J | |
| Pretargeted radioimmunotherapy with Bi-213 in mice with CEA-expressing colon cancer xenografts | 1-gen-2015 | Heskamp, S; Hernandez, R; Essler, M; Bruchertseifer, F; Morgenstern, A; Oyen, W; Seidl, C; Mcbride, B; Goldenberg, D; Boerman, O | |
| Alpha- versus beta-emitting particles for pretargeted radioimmunotherapy of CEA-expressing human colon cancer xenografts | 1-gen-2015 | Heskamp, S; Hernandez, R; Molkenboer-Kuenen, Jdm; Essler, M; Bruchertseifer, F; Morgenstern, A; Oyen, W; Seidl, C; Mcbride, W; Goldenberg, Dm; Boerman, Oc | |
| Tumor segmentation and quantitative assessment of glucose metabolism for different histological types of NSCLC using dynamic F-18-FDG PET | 1-gen-2016 | Meijer, T; De Geus-Oei, Lf; Visser, E; Oyen, W; Looijen-Salamon, M; Visvikis, D; Verhagen, A; Bussink, J; Vriens, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2151
Data di pubblicazione
- 2020 - 2026113
- 2010 - 20191340
- 2000 - 2009587
- 1990 - 1999110
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng794
- ita24
- und6
Accesso al fulltext
- no fulltext2098
- reserved51
- open2